A model that examines the dynamics underlying suicide contagion following a celebrity death could help in developing a rapid response to prevent suicide.
The study by Columbia researchers adds to emerging evidence that environmental metals are preventable risk factors of cardiovascular disease and mortality.
Four Columbia researchers were awarded pilot grants—made possible by proceeds from Velocity, Columbia’s annual cycling fundraiser—to support their early-stage cancer research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Four faculty at Vagelos College of Physicians and Surgeons have been named Irving Scholars and will receive funding to support their clinical research over the next four years.
A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
The EQUIP Center for Learning Health System Science will support researchers working to improve patient safety, particularly among groups that experience persistent health care disparities.
Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Understanding what drives gut stem cells to work nonstop may reveal how idle stem cells elsewhere can be revved up to repair hearts, lungs, and brains. But are scientists studying the right cells?